Related Experiment Videos
Focussed extracorporeal pyrotherapy: experimental results
G Vallancien1, E Chartier-Kastler, D Chopin
1Département d'Urologie, CMC de la Porte de Choisy et CERA, Paris, France.
European Urology
|January 1, 1991
Summary
A novel focused extracorporeal pyrotherapy device uses ultrasound to generate heat and cavitation, effectively destroying deep tissues. This innovative technique shows promise for treating various tumors, including prostate, bladder, kidney, and liver cancers.
Area of Science:
- Medical Devices
- Oncology
- Biophysics
Background:
- Deep tissue ablation often requires invasive procedures.
- Non-invasive methods for precise thermal tissue destruction are needed.
- Current treatments may cause collateral damage to surrounding healthy tissues.
Purpose of the Study:
- To develop and evaluate a new device for focused extracorporeal pyrotherapy.
- To assess the efficacy of focused ultrasound-induced heat and cavitation for tissue ablation.
- To explore potential clinical applications in treating solid tumors.
Main Methods:
- A piezoelectric ceramic device in a semispherical dish was designed for focused ultrasound generation (3.5 MHz).
- In vitro studies used polyurethane phantoms and tissue samples (prostate cancer, BPH) to assess thermal effects and cavitation.
- In vivo studies in pigs involved surgically implanted plastic spheres in the bladder, kidney, and liver to evaluate tissue ablation and healing response.
Main Results:
- In vitro, the device melted 2 x 12 mm surfaces in 1 s on phantoms, reaching 270°C at the focus.
- Tissue samples reached 85°C in vitro, showing hyperechoic zones.
- In vivo, plastic spheres were melted without damaging surrounding tissues; histological analysis showed necrosis and subsequent fibrosis at the treated sites.
Conclusions:
- Focused extracorporeal pyrotherapy effectively ablates deep tissues through combined heat and cavitation.
- The technique demonstrated safety and efficacy in preclinical models, with minimal damage to adjacent tissues.
- Potential indications include prostate, bladder, kidney tumors, and liver metastases.